Call Us Today!
(225) 706-8424

2013 Performance

 

Accountable Care Organization 2013 Quality Performance Summary Statistics Report
TP-ACO L.L.C.
Domain Measure Number Measure Name   TP-ACO Performance Rate  Mean Performance Rate All ACOs 
Patient/Caregiver Experience ACO-1 Getting Timely Care, Appointments, and Information 85.09 81.48
ACO-2 How Well Your Doctors Communicate 95.12 92.96
ACO-3 Patients’ Rating of Doctor 93.37 92.06
ACO-4 Access to Specialists 86.31 85.12
ACO-5 Health Promotion and Education 61.91 58.38
ACO-6 Shared Decision Making 75.91 75.43
ACO-7 Health Status/Functional Status 69.98 71.12
Care Coordination/Patient Safety ACO-8 Risk Standardized, All Condition Readmissions 15.23 14.90
ACO-9 ASC Admissions: COPD or Asthma in Older Adults 1.55 1.17
ACO-10 ASC Admission: HF 1.06 1.2
ACO-11 Percent of Primary Care Providers Who Successfully Attested for the EHR Incentive Program Incentive Payment 54.90% 66.21%
ACO-12 Medication Reconciliation 99.81% 73.56%
ACO-13 Falls: Screening for Fall Risk 94.38% 39.57%
Preventive Health ACO-14 Influenza Immunization 50.35% 56.93%
ACO-15 Pneumococcal Vaccination 69.41% 54.76%
ACO-16 Adult Weight Screening and Follow-up 95.69% 61.61%
ACO-17 Tobacco Use Assessment and Cessation Intervention 99.52% 84.01%
ACO-18 Depression Screening 97.56% 31.19%
ACO-19 Colorectal Cancer Screening 80.58% 59.30%
ACO-20 Mammography Screening 68.78% 62.05%
ACO-21 Proportion of Adults who had blood pressure screened in past 2 years 98.80% 74.25%
At Risk Population Diabetes Composite Beneficiaries with diabetes who met of all the following criteria: 2.18% 22.21%
ACO-22 Hemoglobin A1c Control (HbA1c) (<8 percent) 48.30% 68.58%
ACO-23 Low Density Lipoprotein (LDL) (< 100 mg/dL) 43.93% 54.78%
ACO-24 Blood Pressure (BP) < 140/90 47.09% 69.53%
ACO-25 Tobacco Non-Use 8.25% 63.33%
ACO-26 Aspirin Use 93.26% 74.82%
ACO-27 Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent) 44.66% 22.11%
ACO-28 Percent of beneficiaries with hypertension whose BP < 140/90 46.25% 67.79%
ACO-29 Percent of beneficiaries with IVD with complete lipid profile and LDL control < 100mg/dl 46.99% 55.44%
ACO-30 Percent of beneficiaries who use Aspirin or other antithrombotic 91.57% 76.35%
ACO-31 Beta-Blocker Therapy for LVSD 99.00% 79.82%
CAD Composite Percent of beneficiaries with CAD  who met all of the following criteria: 89.83% 62.78%
ACO-32 Drug Therapy for Lowering LDL-Cholesterol 90.56% 71.60%
ACO-33 (ACE) Inhibitor or (ARB) Therapy for Patients with CAD and Diabetes and/or (LVSD) 97.47% 69.13%